Search

糖尿病足是糖尿病最严重的并发症之一，治疗费用高，预后较差。近年来，以肠促胰素 为基础的降糖药物已成为2型糖尿病的重要治疗策略。既往研究表明，肠促胰素类药物具有抗炎、抗 氧化、促进血管生成和增强组织重塑的作用，这表明其对糖尿病创面愈合有潜在的益处。同时，部分 肠促胰素类药物已被证明具有抗动脉粥样硬化和神经保护作用，故肠促胰素类药物可能成为难治性 糖尿病足溃疡新的辅助治疗策略。该文对肠促胰素类药物在糖尿病足创面愈合中的潜在作用及机制 进行综述。 [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Diabetes Mellitus is the property of Chinese Journal of Diabetes Mellitus and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)